Stanford University Regional Coordinating Stroke Center for the NIH Stroke Trials Network

项目摘要 成立了斯坦福大学中风中心，这是同类中心中最早的综合性多学科中心之一 在1992年开发新的方法来诊断和治疗中风。中风中心的使命是成为 美国最好的综合性组织，专注于中风的诊断，治疗，研究， 教育1992年，该中心由一组神经学家、神经外科医生、神经放射学家， 护理专家、基础科学家和临床研究人员。这个跨专业小组定期举行会议， 30年来不断完善该计划。2012年，联合委员会和美国心脏 协会/美国中风协会宣布，斯坦福大学中风中心是第一家医院， 美国将达到联合委员会的疾病特异性护理综合中风标准 中心认证。 斯坦福大学被选为最初的中风网络区域协调中心（RCC）之一。在过去 10年来，斯坦福大学对该网络的主要贡献之一包括开发DEFUSE 3研究， 这是第一个由StrokeNet资助和执行的临床试验， 世界各地的指南和临床实践。此外，斯坦福大学的区域网络是最高的之一 StrokeNet研究的注册者和斯坦福大学的教师为StrokeNet的主要委员会做出了重大贡献。 斯坦福-RCC仍然完全致力于继续为不同的患者提供大量入组 在当前StrokeNet结束之间的过渡期内， 段和新段。斯坦福大学RCC已经选择了下一个StrokeNet培训生，并将继续 提供创新的多学科奖学金计划，提供临床试验的全面培训 设计、实施和分析。

PROJECT SUMMARY The Stanford Stroke Center, one of the first comprehensive multidisciplinary centers of its kind, was established in 1992 to develop new approaches to diagnose and treat stroke. The mission of the Stroke Center is to be the best comprehensive organization in the United States focused on stroke diagnosis, treatment, research, and education. In 1992, the Center was established by a team of neurologists, neurosurgeons, neuroradiologists, nurse specialists, basic scientists, and clinical researchers. This multi-disciplinary team has met regularly to continually refine the program for 30 years. In 2012, the Joint Commission and the American Heart Association/American Stroke Association announced that the Stanford Stroke Center was the first hospital in the United States to meet The Joint Commission's standards for Disease-Specific Care Comprehensive Stroke Center Certification. Stanford was chosen to be one of the original StrokeNet Regional Coordinating Centers (RCCs). During the past 10 years, one of Stanford’s major contributions to the network included the development of the DEFUSE 3 study, which became the first clinical trial to be funded and executed by StrokeNet and which changed stroke practice guidelines and clinical practice around the world. In addition, Stanford’s regional network is one of the highest enrollers in StrokeNet studies and Stanford faculty have made major contributions to key StrokeNet committees. The Stanford-RCC remains fully committed to continue to provide high volume enrollment of diverse patient populations into NINDS funded stroke trials during the transition period between the end of the current StrokeNet segment and the new segment. The Stanford RCC has selected the next StrokeNet trainee and will continue to offer an innovative multidisciplinary fellowship program that provides comprehensive training in clinical trial design, implementation and analysis.